CASTLE BIOSCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CASTLE BIOSCIENCES, INC. (CSTL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.38 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 7.38M shares, a 32.97% increase year-over-year.
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 6.97M shares, a 1.06% increase year-over-year.
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 7.37M shares, a 140.90% increase year-over-year.
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 5.55M shares, a 54.30% increase year-over-year.
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.17M shares, a 128.67% increase from fiscal 2024.
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.14M shares, a 55.19% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.00M shares, a 31.63% increase from fiscal 2022.
- CASTLE BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 5.32M shares, a 51.01% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 7.38M shares 10-Q · filed 2026-07-30 | 7.17M shares 10-Q · filed 2026-07-30 | |||||
| 2026-03-31 | 6.97M shares 10-Q · filed 2026-05-06 | ||||||
| 2025-12-31 | 7.17M shares 10-K · filed 2026-02-26 | ||||||
| 2025-09-30 | 7.37M shares 10-Q · filed 2025-11-03 | 7.17M shares 10-Q · filed 2025-11-03 | |||||
| 2025-06-30 | 5.55M shares 10-Q · filed 2026-07-30 | 7.17M shares 10-Q · filed 2026-07-30 | |||||
| 2025-03-31 | 6.90M shares 10-Q · filed 2026-05-06 | ||||||
| 2024-12-31 | 3.14M shares 10-K · filed 2026-02-26 | ||||||
| 2024-09-30 | 3.06M shares 10-Q · filed 2025-11-03 | 3.23M shares 10-Q · filed 2025-11-03 | |||||
| 2024-06-30 | 3.60M shares 10-Q · filed 2025-08-04 | 3.60M shares 10-Q · filed 2025-08-04 | |||||
| 2024-03-31 | 6.66M shares 10-Q · filed 2025-05-05 | ||||||
| 2023-12-31 | 7.00M shares 10-K · filed 2026-02-26 | ||||||
| 2023-09-30 | 7.09M shares 10-Q · filed 2024-11-04 | 7.06M shares 10-Q · filed 2024-11-04 | |||||
| 2023-06-30 | 7.20M shares 10-Q · filed 2024-08-05 | 7.24M shares 10-Q · filed 2024-08-05 | |||||
| 2023-03-31 | 7.09M shares 10-Q · filed 2024-05-02 | ||||||
| 2022-12-31 | 5.32M shares 10-K · filed 2025-02-27 | ||||||
| 2022-09-30 | 5.45M shares 10-Q · filed 2023-11-02 | 5.11M shares 10-Q · filed 2023-11-02 | |||||
| 2022-06-30 | 5.08M shares 10-Q · filed 2023-08-02 | 4.93M shares 10-Q · filed 2023-08-02 | |||||
| 2022-03-31 | 4.77M shares 10-Q · filed 2023-05-03 | ||||||
| 2021-12-31 | 3.52M shares 10-K · filed 2023-02-28 | ||||||
| 2021-09-30 | 3.43M shares 10-Q · filed 2022-11-02 | 3.46M shares 10-Q · filed 2022-11-02 | |||||
| 2021-06-30 | 3.43M shares 10-Q · filed 2022-08-08 | 3.48M shares 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | 3.54M shares 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | 2.92M shares 10-K · filed 2022-02-28 | ||||||
| 2020-09-30 | 2.90M shares 10-Q · filed 2021-11-08 | 2.87M shares 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | 2.87M shares 10-Q · filed 2021-08-09 | 2.85M shares 10-Q · filed 2021-08-09 | |||||
| 2020-03-31 | 969.00K shares 10-Q · filed 2021-05-10 | ||||||
| 2019-12-31 | 6.68M shares 10-K · filed 2021-03-11 | ||||||
| 2019-09-30 | 2.80M shares 10-Q · filed 2020-11-09 | 2.80M shares 10-Q · filed 2019-11-12 | 8.21M shares 10-Q · filed 2020-11-09 | 8.22M shares 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | 11.13M shares 10-Q · filed 2020-08-10 | 10.87M shares 10-Q · filed 2020-08-10 | 11.14M shares 10-Q · filed 2019-09-03 | ||||
| 2019-03-31 | 10.60M shares 10-Q · filed 2020-05-11 | ||||||
| 2018-12-31 | 9.41M shares 10-K · filed 2020-03-10 | ||||||
| 2018-09-30 | 9.82M shares 10-Q · filed 2019-11-12 | 9.23M shares 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | 9.87M shares 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |